Cargando…
Extracellular and intraneuronal HMW-AbetaOs represent a molecular basis of memory loss in Alzheimer's disease model mouse
BACKGROUND: Several lines of evidence indicate that memory loss represents a synaptic failure caused by soluble amyloid β (Aβ) oligomers. However, the pathological relevance of Aβ oligomers (AβOs) as the trigger of synaptic or neuronal degeneration, and the possible mechanism underlying the neurotox...
Autores principales: | Takamura, Ayumi, Okamoto , Yasuhide, Kawarabayashi, Takeshi, Yokoseki, Tatsuki, Shibata, Masao, Mouri, Akihiko, Nabeshima, Toshitaka, Sun, Hui, Abe, Koji, Urisu, Tsuneo, Yamamoto, Naoki, Shoji, Mikio, Yanagisawa, Katsuhiko, Michikawa, Makoto, Matsubara, Etsuro |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061944/ https://www.ncbi.nlm.nih.gov/pubmed/21375782 http://dx.doi.org/10.1186/1750-1326-6-20 |
Ejemplares similares
-
Disease Modifying Therapies for Alzheimer's Disease Targeting Aβ Oligomers: Implications for Therapeutic Mechanisms
por: Matsubara, Etsuro, et al.
Publicado: (2013) -
Intraneuronal pyroglutamate-Abeta 3–42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model
por: Wirths, Oliver, et al.
Publicado: (2009) -
N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody
por: Antonios, Gregory, et al.
Publicado: (2013) -
Is abeta a sufficient biomarker for monitoring anti-abeta clinical studies? A critical review
por: Moreth, Jens, et al.
Publicado: (2013) -
Site specific NMR characterization of abeta-40 oligomers cross seeded by abeta-42 oligomers
por: Chang, Han-Wen, et al.
Publicado: (2022)